coronavirus

The new coronavirus strain, first discovered in the central city of Wuhan, has caused alarm because of its connection to Severe Acute Respiratory Syndrome (SARS), which killed nearly 650 people across mainland China and Hong Kong in 2002-2003. More

Jump to
735 Results Found
  • Coronavirus vaccine update: Russia's Sputnik V likely to be available for supply from January Dec 01, 2020 05:21 PM IST

    Coronavirus vaccine update: Russia's Sputnik V likely to be available for supply from January

    According to RDIF COO Kirill Dmitriev, regulatory approval for the vaccine is expected by January 2021, and it should be available for supply soon after.

  • Explained | Why 2021 may not be a happy new year for showbiz Nov 28, 2020 12:17 PM IST

    Explained | Why 2021 may not be a happy new year for showbiz

    We know that shooting and production halted for a few months amid the pandemic. Find more about the disruption in showbiz here.

  • Q2 GDP Data Highlights | India enters recession as GDP contracts 7.5%, but experts see V-shaped recovery Nov 27, 2020 03:01 PM IST

    Q2 GDP Data Highlights | India enters recession as GDP contracts 7.5%, but experts see V-shaped recovery

    CEA Krishnamurthy Subramanian stated that each of the high frequency indicators were doing well till February until COVID-19 hit, while CSO Kshatrapati Shivaji sees V-shaped recovery.

  • FMCG industry sees signs of recovery in September quarter: Nielsen Nov 27, 2020 09:40 AM IST

    FMCG industry sees signs of recovery in September quarter: Nielsen

    The growth witnessed in the fast-moving consumer goods (FMCG) sector was also a reflection of positivity witnessed in the overall macroeconomic scenario amid opening up of the economy and easing of lockdown restrictions

  • COVID-19 impact | Disney to layoff about 32,000 workers in first half of 2021 Nov 26, 2020 12:15 PM IST

    COVID-19 impact | Disney to layoff about 32,000 workers in first half of 2021

    Earlier this month, Disney said it was furloughing additional workers from its theme park in Southern California due to uncertainty over when the state would allow parks to reopen.

  • Big Story | OPEC to determine course of oil markets in 2021: What to expect from its upcoming meet Nov 24, 2020 06:09 PM IST

    Big Story | OPEC to determine course of oil markets in 2021: What to expect from its upcoming meet

    Oil prices rose more than 1% on Nov 23, extending last week's gains as traders anticipated coronavirus vaccine trials would spur a recovery in demand. OPEC officials will meet this week on November 25, November 26 and November 27. Let's find out what we can expect in the upcoming meet

  • 3-Point Analysis | Why AstraZeneca's COVID vaccine may be more suitable for India than Pfizer, Moderna shots Nov 24, 2020 02:40 PM IST

    3-Point Analysis | Why AstraZeneca's COVID vaccine may be more suitable for India than Pfizer, Moderna shots

    Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.

  • Big Story | How Pfizer, Moderna, AstraZeneca COVID-19 vaccines are placed in terms of availability? Nov 23, 2020 06:13 PM IST

    Big Story | How Pfizer, Moderna, AstraZeneca COVID-19 vaccines are placed in terms of availability?

    The last two weeks have seen a string of encouraging results from COVID-19 vaccine trials with several experimental vaccines having proved over 90% effectiveness at preventing disease in late-stage clinical trials. Let's find out if the hunt for the vaccine over

  • Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine Nov 23, 2020 05:03 PM IST

    Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine

    Moderna’s CEO has said the company will charge governments $25 and $37 per dose for its COVID-19 vaccine

  • AstraZeneca will have 200 million COVID-19 vaccine doses by year-end Nov 23, 2020 04:41 PM IST

    AstraZeneca will have 200 million COVID-19 vaccine doses by year-end

    Pam Cheng said there would be enough vaccine for 20 million doses in Britain by the end of the year, with enough "active" drug substance for 70 million doses for the UK by the end of Q1 2021.

  • Coronavirus vaccine: Oxford, AstraZeneca say their candidate prevents average 70% people from getting COVID Nov 23, 2020 01:12 PM IST

    Coronavirus vaccine: Oxford, AstraZeneca say their candidate prevents average 70% people from getting COVID

    In India, Serum Institute of India (SII) is conducting clinical trials of the Oxford-AstraZeneca vaccine against COVID-19.

  • Coronavirus vaccine update: US likely to get COVID-19 vaccine by mid-December -- when can India expect it? Nov 23, 2020 11:24 AM IST

    Coronavirus vaccine update: US likely to get COVID-19 vaccine by mid-December -- when can India expect it?

    Currently, five coronavirus vaccine candidates are under different phases of clinical trials in India.

  • Big Story | Pfizer-BioNTech's COVID-19 vaccine deliveries may start before Christmas Nov 19, 2020 07:04 PM IST

    Big Story | Pfizer-BioNTech's COVID-19 vaccine deliveries may start before Christmas

    Pharmaceutical giant Pfizer Inc and its partner BioNTech SE are all set to seek emergency authorisation for its COVID-19 vaccine.

  • Big Story | Moderna becomes 2nd company to claim its experimental vaccine effective in preventing COVID-19 Nov 17, 2020 06:10 PM IST

    Big Story | Moderna becomes 2nd company to claim its experimental vaccine effective in preventing COVID-19

    With American pharma giant Moderna claiming that its experimental vaccine is effective in preventing COVID-19, it has become the second firm after the Pfizer vaccine to release late-stage trial results.

  • Explained: Why Moderna’s Covid-19 vaccine scores over Pfizer’s jab, and why it could be a compelling option for India Nov 17, 2020 12:03 PM IST

    Explained: Why Moderna’s Covid-19 vaccine scores over Pfizer’s jab, and why it could be a compelling option for India

    Moderna’s vaccine remains stable for 30 days when refrigerated at 2-8 degrees Celsius and is stable for 12 hours at room temperature. For longer-term storage and shipping, it needs to be kept at minus 20 degrees Celsius, a temperature that distributors can deal with. The Pfizer-BioNTech vaccine has to be stored at about minus 70 degrees Celsius, requiring ultra-cold storage.

  • Australia to spend $726 million underwriting country's biggest vaccine plant Nov 16, 2020 11:38 AM IST

    Australia to spend $726 million underwriting country's biggest vaccine plant

    Under the deal, CSL vaccine subsidiary Seqirus would spend A$800 million building the facility in the city of Melbourne

  • Indian economy may be recovering faster than anticipated: Oxford Economics Nov 15, 2020 11:48 AM IST

    Indian economy may be recovering faster than anticipated: Oxford Economics

    Oxford Economics further said that inflation is expected to average significantly above 6 percent in the fourth quarter of the current fiscal and the RBI may hold policy rates in December monetary policy review meeting.

  • Alibaba Singles Day sales hit $56 billion with record peak of 583,000 orders per second Nov 11, 2020 11:57 AM IST

    Alibaba Singles Day sales hit $56 billion with record peak of 583,000 orders per second

    This is being viewed as another indicator of China’s “economic rebound” from the pandemic after the coronavirus emerged in Wuhan last year, as Alibaba is not the only player seeing big numbers

  • In the south, fewer Chinese items, COVID-19 scare dim Diwali—Part II Nov 10, 2020 04:55 PM IST

    In the south, fewer Chinese items, COVID-19 scare dim Diwali—Part II

    Unlike in the north, a shortage of economically-priced Chinese products such as festive lights has resulted in fewer customers this season. This is the second of a three-part series

  • Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious Nov 10, 2020 08:10 AM IST

    Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

    The drugmakers said their vaccine was more than 90 percent effective at preventing COVID-19, based on data from the first 94 people in the trial to become infected with the coronavirus.

  • We may soon have a COVID-19 vaccine. But will enough people take it? Nov 10, 2020 08:05 AM IST

    We may soon have a COVID-19 vaccine. But will enough people take it?

    Public resistance to vaccines has been much discussed this year, but the issue became very real on Monday when Pfizer and BioNTech announced their candidate was more than 90% effective in large trials - hoisting an actual shot onto the horizon.

  • Five things to know about Pfizer's COVID-19 vaccine that's 90% effective, including India availability Nov 09, 2020 07:47 PM IST

    Five things to know about Pfizer's COVID-19 vaccine that's 90% effective, including India availability

    The potential COVID-19 vaccine was found to be more than 90 percent effective in preventing the disease in participants who had no prior history of SARS-CoV-2 infection.

  • Pfizer COVID-19 vaccine breakthrough: Medicine, stock market experts weigh in Nov 09, 2020 06:54 PM IST

    Pfizer COVID-19 vaccine breakthrough: Medicine, stock market experts weigh in

    Pfizer and German partner BioNTech SE are the first drug makers to show successful data from a large-scale clinical trial of a coronavirus vaccine. Here are some experts' views

  • COVID-19 update | Pfizer-BioNTech vaccine candidate more than 90% effective — read Pfizer boss Albert Bourla's full statement here Nov 09, 2020 06:26 PM IST

    COVID-19 update | Pfizer-BioNTech vaccine candidate more than 90% effective — read Pfizer boss Albert Bourla's full statement here

    Pfizer on November 9 claimed that its vaccine data suggests the shots may be 90 percent effective at preventing the pandemic.

  • Pfizer's COVID-19 vaccine is over 90% effective, shows data Nov 09, 2020 05:42 PM IST

    Pfizer's COVID-19 vaccine is over 90% effective, shows data

    Pfizer and BioNTech's COVID-19 Vaccine: The phase 3 trials have involved more than 43,000 people and across diverse backgrounds. According to the company, gathering the required safety data will take until the third week of November this year.

Sections